Arax Advisory Partners’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
13,205
+13,113
+14,253% +$927K 0.01% 1167
2026
Q1
$5.85K Buy
92
+75
+441% +$4.84K ﹤0.01% 2711
2025
Q4
$1.05K Sell
17
-13,091
-100% -$748K ﹤0.01% 3470
2025
Q3
$687K Buy
13,108
+13,059
+26,651% +$657K 0.01% 779
2025
Q2
$2.21K Buy
+49
New +$2.02K ﹤0.01% 2541
2024
Q4
Sell
-37
Closed -$1.94K 2601
2024
Q3
$1.94K Hold
37
﹤0.01% 2074
2024
Q2
$2.03K Buy
+37
New +$2.11K ﹤0.01% 1966

Other funds holding LIVN

Arax Advisory Partners's LIVN Position: Q2 2026 in Review

Arax Advisory Partners increased its LivaNova (LIVN) stake by 14,253% in Q2 2026, buying an estimated $927K and bringing the position to 13,205 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #1167.

Arax Advisory Partners first reported a position in LIVN in Q2 2024 and has held it in 7 quarters since. 303 funds tracked by Wall St. Rank hold LIVN as of Q2 2026.

  • Arax Advisory Partners held 13,205 shares of LivaNova worth $1.09M as of Q2 2026.
  • Arax Advisory Partners bought 13,113 LivaNova shares in Q2 2026, an estimated $927K.
  • LivaNova made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1167 holding.
  • Arax Advisory Partners first reported a position in LivaNova in Q2 2024 and has held it in 7 quarters since.
  • 303 funds tracked by Wall St. Rank held LivaNova as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.